As a result of using Defendants Ozempic and Mounjaro, Plaintiff was caused to suffer from severe gastrointestinal events, which resulted in, for example, severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room, teeth falling out due to excessive vomiting, requiring additional medications to alleviate her excessive vomiting, and throwing up whole food hours after eating. The lawsuit explains: Defendants acknowledge that gastrointestinal events are well known side effects of the GLP-1 class
P.ZhouJ.BondyC.LupuF.BellvA
Given its beneficial effects on glucose regulation and appetite control, GLP-1 has been harnessed pharmacologically through the development of GLP-1 receptor agonists they are used in treating type 2 diabetes and obesity with significant results: Medications : Examples include liraglutide, semaglutide, and dulaglutide
The GshF activities were similar for all three strains when the IPTG concentration was 0.5 mM for ZJ1234 and ZJ12345 and 0.05 mM for ZJ000
By week 20 she had lost about 42 pounds and I was down 34
